Anjarium Biosciences’ CHF 55.5 Million Series A Financing Round

Federica Tiefenthaler
Tagged:

VISCHER advised Anjarium Biosciences on the deal. Baker McKenzie advises a consortium of life science funds, including Abingworth and Gimv, alongside Omega Funds, Pfizer Ventures and…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now